on HBM Healthcare Investments AG (ETR:CH001262)
HBM Healthcare Investments' Shareholders Approve Key Proposals
In the recent Shareholders' Meeting, HBM Healthcare Investments AG successfully gained approval for all board proposals. Hans Peter Hasler, Chairman, along with board members Dr. Rudolf Lanz, Mario G. Giuliani, Dr. Stella X. Xu, and Dr. Elaine V. Jones, have been re-elected for another year. Similarly, the Compensation Committee members remain unchanged
The shareholders consented to a capital reduction by cancelling 125,000 treasury shares from the 2025 buyback program. Additionally, a dividend of CHF 9.00 per share was ratified, set for payment on June 19, 2026. The ex-dividend date is June 17, 2026.
The presentation from the meeting is available on HBM's website. For inquiries, Dr. Andreas Wicki is the primary contact.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all HBM Healthcare Investments AG news